HIV, Hepatitis B and C among people who inject drugs: High prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India

BMC Public Health

Volumn 15, Issue 1, 2015, Pages

  Ray Saraswati, Lopamudra ^a   Sarna, Avina ^a   Sebastian, Mary Philip ^a   Sharma, Vartika ^a   Madan, Ira ^b   Thior, Ibou ^c   Pulerwitz, Julie ^c,d   Tun, Waimar ^d  

^a Habitat Centre   (India)

^b Sahara Centre for Residential Care and Rehabilitation   (India)

^c PATH   (United States)

^d POPULATION COUNCIL   (United States)

Author keywords

Hepatitis B; Hepatitis C; HIV; HIV HCV co infection; India; People Who Inject Drugs (PWID)

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; BLOOD; COINFECTION; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMAN; INCIDENCE; INDIA; MALE; PREVALENCE; REGRESSION ANALYSIS; SEROLOGY; SUBSTANCE ABUSE; TIME FACTOR;

ADULT; COINFECTION; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HUMANS; INCIDENCE; INDIA; MALE; PREVALENCE; REGRESSION ANALYSIS; RNA, VIRAL; SEROLOGIC TESTS; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 84938884035     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-015-2003-z     Document Type: Article

References (36)

1. Crofts N, Dore G, Locarnini (Eds.) S. Hepatitis C: an Australian perspective. IP Communications: East Hawthorn; 2001.
2. Mehta SH, Vogt SL, Srikrishnan AK, Vasudevan CK, Murugavel KG, Saravanan S, et al. Epidemiology of hepatitis C virus infection & liver disease among injection drug users (IDUs) in Chennai, India. Indian J Med Res. 2010;132:706-14.
3. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349(9055):825-32.
4. Dore GJ, Freeman AJ, Law M, Kaldor JM. Is severe liver disease a common outcome for people with chronic hepatitis C? J Gastroenterol Hepatol. 2002;17(4):423-30.
5. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;32(3):492-7.
6. Silver D, Karnik G, Osinusi A, Silk R, Stabinski L, Doonquah L, et al. Effect of HIV on liver fibrosis among HCV-infected African Americans. Clin Infect Dis. 2013;56(9):1280-3.
7. Puoti M, Spinetti A, Ghezzi A, Donato F, Zaltron S, Putzolu V, et al. Mortality for liver disease in patients with HIV infection: a cohort study. J Acquir Immune Defic Syndr. 2000;24(3):211-7.
8. Solomon SS, Hawcroft CS, Narasimhan P, Subbaraman R, Srikrishnan AK, Cecelia AJ, et al. Comorbidities among HIV-infected injection drug users in Chennai. India Indian J Med Res. 2008;127(5):447-52.
9. Solomon SS, Srikrishnan AK, Mehta SH, Vasudevan CK, Murugavel KG, Thamburaj E, et al. High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern. J Acquir Immune Defic Syndr. 2008;49(3):327-32.
10. Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis. 2010;14(1):1-21. vii.
11. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45(4):529-38.
12. NACO. Annual Report 2012-13. New Delhi: National AIDS Control Organization, Department of AIDS Control, Ministry of Health and Family Welfare, Government of India; 2013.
13. Mahanta J, Medhi GK, Paranjape RS, Roy N, Kohli A, Akoijam BS, et al. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India. AIDS 2008;22(5):S59-68.
14. Saha MK, Chakrabarti S, Panda S, Naik TN, Manna B, Chatterjee A, et al. Prevalence of HCV & HBV infection amongst HIV seropositive intravenous drug users & their non-injecting wives in Manipur, India. Indian J Med Res. 2000;111:37-9.
15. Devi Kh S, Brajachand N, Singh HL, Singh YM. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users. J Commun Dis. 2005;37(1):73-7.
16. Baveja UK, Chattopadhya D, Khera R, Joshi PM. A cross sectional serological study of the co-infection of hepatitis B virus, hepatitis C virus and human immunodeficiency virus amongst a cohort of IDUs at Delhi. Indian J Med Microbiol. 2003;21(4):280-3.
17. Basu D, Kumar V, Sharma AK, Barnwal PK, Mattoo SK. Seroprevalence of anti-hepatitis C virus (anti-HCV) antibody and HCV-related risk in injecting drug users in northern India: Comparison with non-injecting drug users. Asian Journal of Psychiatry. 2013;6(1):52-5.
18. Panda S, Roy T, Pahari S, Mehraa J, Sharma N, Singh G, et al. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates. Int J STD AIDS, 2013;25(8):596-606.
19. Sarna A, Tun W, Bhattacharya A, Lewis D, Singh YS, Apicella L. Assessment of unsafe injection practices and sexual behaviors among male injecting drug users in two urban cities of India using respondent driven sampling. Southeast Asian J Trop Med Public Health. 2012;43(3):652-67.
20. Sarna A, Tun W, Sharma V, Sebastian M, Madan I, Yadav A, et al. High uptake of HIV testing in a cohort of male injection drug users in Delhi, India: prevalence and correlates of HIV infection. AIDS Behav. 2013;17(7):2479-89.
21. Tun W, Sebastian MP, Sharma V, Madan I, Souidi S, Lewis D, et al. Strategies for recruiting injection drug users for HIV prevention services in Delhi. India Harm Reduct J. 2013;10(1):16.
22. NACO. HIV Sentinel Surveillance 2010-11: A Technical Brief.: National AIDS Control Organization, Department of AIDS Control, Ministry of Health and Family Welfare, Government of India; 2012.
23. Solomon S, Mehta S, Srikrishnan A, Solomon S, McFall A, Laeyendecker O, et al. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study. Lancet Infectious Disease. 2015;15(1):36-45.
24. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011;378(9791):571-83.
25. Mahanta J, Borkakoty B, Das HK, Chelleng PK. The risk of HIV and HCV infections among injection drug users in northeast India. AIDS Care. 2009;21(11):1420-4.
26. Chelleng PK, Borkakoty BJ, Chetia M, Das HK, Mahanta J. Risk of hepatitis C infection among injection drug users in Mizoram. India Indian J Med Res. 2008;128(5):640-6.
27. Crofts N. Going where the epidemic is. Epidemiology and control of hepatitis C among injecting drug users. Aust Fam Physician. 2001;30(5):420-5.
28. Paintsil E, Binka M, Patel A, Lindenbach BD, Heimer R. Hepatitis C Virus Maintains Infectivity for Weeks After Drying on Inanimate Surfaces at Room Temperature: Implications for Risks of Transmission. J Infect Dis 2014;209(8):1205-11.
29. Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL. Harrison's Principles of Internal Medicine, USA. 15th Edition. Volume 2. McGraw-Hill Professional Publishing; 2001.
30. Ibarra RT. Treatment of HBV-HCV coinfection. Annals of Hepatology. 2006;5 Suppl 1:S49-52.
31. Fan CL, Wei L, Jiang D, Chen HS, Gao Y, Li RB, et al. Clinical and virological course of dual infection by hepatitis B and C viruses in China. Zhonghua Yi Xue Za Zhi. 2003;83(14):1214-8.
32. Sterling RK, Sulkowski MS. Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection. Semin Liver Dis. 2004;24(Suppl 2):61-8.
33. Liu Z, Hou J. Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection. Int J Med Sci. 2006;3(2):57-62.
34. Ambekar A. Association of Drug Use Pattern with Vulnerability and Service Uptakeamong Injecting Drug Users. Regional Office for South Asia, India: National AIDS Control Organization and United Nations Office of Drugs and Crime; 2012.
35. International Institute for Population Sciences (IIPS) and Macro International. National Family Health Survey (NFHS-3), 2005-06. Report. IPS, Mumbai, India. 2007.
36. Wattana W, Griensven F, Rhucharoenpornpanich O, Manopaiboon C, Thienkrua W, Bannatham R, et al. Respondent driven sampling to assess characteristics and estimate the number of injection drug users in Bangkok, Thailand. Drug and Alcohol Dependence. 2007;90:228-33.